Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Mercuric amidochloride is an inorganic compound with the formula Hg(NH₂)Cl. It is a white crystalline solid that was historically used as a topical antiseptic and disinfectant, particularly in creams for the treatment of psoriasis and as an anti-infective agent in some skin-lightening formulations. The compound arises from the reaction of ammonia and mercuric chloride, forming a zig-zag 1-dimensional polymer structure with chloride counterions. Mercuric amidochloride is highly toxic by inhalation, ingestion, or dermal absorption and can cause severe health effects including dermatitis, mucous membrane corrosion, or death. Due to its toxicity and environmental hazards associated with mercury compounds, it is no longer widely used in medicine[1][3][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Mercuric amidochloride.